Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Blood culture Stories

2014-04-08 12:31:11

WOBURN, Mass. and VEDBAEK, Denmark, April 8, 2014 /PRNewswire/ -- AdvanDx, Inc. today announced it has closed a $12 million financing led by Merck Global Health Innovation Fund (Merck GHI) with participation from existing investors SLS Ventures AB and LD Pensions. The Series B-1 financing will be used to fund the expansion of AdvanDx's molecular diagnostic product offerings, as well as its sales and marketing presence in the U.S. and internationally. "We continue to see increased...

2013-11-19 13:02:22

A new method could cut hours off the time it takes to diagnose blood infections while also eliminating the need for complicated manual processing and expensive equipment, according to a report to be published in mBio®, the online open-access journal of the American Society for Microbiology, on November 19. The method combines a selective lysis step in which blood cells in the sample are destroyed, a centrifugation step to collect any bacteria or fungi in the sample, and a fluorescence step...

2013-10-03 12:27:02

Today at IDWeek, the Cleveland Clinic presented results of a study demonstrating identification of pathogenic yeasts with Specific Technologies blood culture system with 97% accuracy 4 times faster (2 days sooner) than current standard practice. MOUNTAIN VIEW, Calif., Oct. 3, 2013 /PRNewswire-iReach/ -- Today at IDWeek, the Cleveland Clinic presented results of a study demonstrating identification of pathogenic yeasts with Specific Technologies blood culture system with 97% accuracy...

2013-09-09 11:35:52

Disease-causing bacteria stink — literally — and the odor released by some of the nastiest microbes has become the basis for a faster and simpler new way to diagnose blood infections and finger the specific microbe, scientists reported here today at the 246th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society. The new test produces results in 24 hours, compared to as much as 72 hours required with the test hospitals now use,...

2013-08-13 12:27:18

Gram-Negative QuickFISH Blood Culture is the third FDA-cleared test in AdvanDx's QuickFISH pathogen identification platform, the first and only molecular tests fast enough to report pathogen identification with Gram stain results WOBURN, Mass., Aug. 13, 2013 /PRNewswire-iReach/ -- AdvanDx, Inc., a leading provider of molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients, announces the commercial launch of Gram-NegativeQuickFISH BC....

2013-05-20 16:25:41

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Today at American Society for Microbiology conference, award lecturer Dr. Christine Ginocchio discussed Specific Technologies blood culture system as an upcoming solution for rapid identification of microorganisms producing bloodstream infection. Dr. Ginocchio is the Senior Medical Director and Chief of the Division of Infectious Disease Diagnostics at North Shore-LIJ Health System, the nation's 2nd largest not-for-profit,...

2013-02-28 08:29:52

Blood Culture Systems Comparison Study Shows BD BACTEC(TM) Plus Aerobic Medium Provides Statistically Significant Differences in Bacterial Recovery for Patients on Antimicrobial Therapy BALTIMORE, Feb. 28, 2013 /PRNewswire/ -- A new study, published in the journal Clinical Infectious Diseases, demonstrates how treatment with broad-spectrum antibiotics can impact the ability to detect bacteria in blood samples from potentially septic patients. It also highlights the importance of...

2012-01-18 03:00:00

CARLSBAD, Calif., Jan. 18, 2012 /PRNewswire/ -- Ivera Medical Corporation today announced it has received a new FDA 510(k) clearance for its Curos® disinfecting port protector which reflects the company's ongoing determination to continuously improve its products to better deliver solutions designed to reduce hospital-acquired catheter related bloodstream infections. The Curos passive disinfection cap first received 510(k) clearance in 2008. The new 510(k) clears Curos for improved...

2011-10-13 09:46:09

Replacing conventional laboratory tests with a new DNA sequence-based technology to identify pathogens causing bloodstream infections dramatically lowered mortality and health-care costs, a clinical study conducted by an interdisciplinary UA research team found. Unlike conventional laboratory tests, a new technology called PNA-FISH is designed to rapidly identify bloodstream pathogens by their genetic code. Results are available within hours instead of days providing pharmacists and...

2011-10-13 07:00:00

WOBURN, Mass. and COPENHAGEN, Denmark, Oct. 13, 2011 /PRNewswire/ -- A new study documents significant decreases in ICU mortality and hospital costs for patients with bloodstream infections after implementation of PNA FISH tests for rapid identification of bloodstream pathogens. The study was performed at The University of Arizona Medical Center - University Campus (Tucson, Arizona) in a collaboration between the clinical microbiology laboratory and infectious diseases pharmacists as part...